Andy
Senior Member (Voting rights)
From the video description,
"In this conversation, we discuss the importance of funding for research in the charity sector, specifically for ME, CFS, and long COVID. The majority of research funding comes from charities, with only a small percentage coming from the government for other diseases, hence the need to emphasise the power of an established and reputable organisation in the charity sector. The example of the Cystic Fibrosis Trust is an inspiring case of how focused efforts and resources can lead to significant improvements in a niche illness. We compare the fundraising efforts for ME/CFS with other diseases like MND and Parkinson's, noting the disparity in funding despite the lower number of people affected by ME/CFS.
Hopefully this provides an overview of why the charity sector is so important, and inspiring that even diseases with low numbers of people were able to drive such huge change!"
Tweet from Peter White, who was the interviewee.
"A major cause of poor #MECFS and #LongCovid research funding is poor fundraising and fund spending by the UK ME charity sector. Here's an overview of charity research spending by disease, showing performance against comparable diseases."
"In this conversation, we discuss the importance of funding for research in the charity sector, specifically for ME, CFS, and long COVID. The majority of research funding comes from charities, with only a small percentage coming from the government for other diseases, hence the need to emphasise the power of an established and reputable organisation in the charity sector. The example of the Cystic Fibrosis Trust is an inspiring case of how focused efforts and resources can lead to significant improvements in a niche illness. We compare the fundraising efforts for ME/CFS with other diseases like MND and Parkinson's, noting the disparity in funding despite the lower number of people affected by ME/CFS.
Hopefully this provides an overview of why the charity sector is so important, and inspiring that even diseases with low numbers of people were able to drive such huge change!"
Tweet from Peter White, who was the interviewee.
"A major cause of poor #MECFS and #LongCovid research funding is poor fundraising and fund spending by the UK ME charity sector. Here's an overview of charity research spending by disease, showing performance against comparable diseases."